<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Afr Med</journal-id><journal-id journal-id-type="iso-abbrev">Ann Afr Med</journal-id><journal-id journal-id-type="publisher-id">AAM</journal-id><journal-title-group><journal-title>Annals of African Medicine</journal-title></journal-title-group><issn pub-type="ppub">1596-3519</issn><issn pub-type="epub">0975-5764</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27549415</article-id><article-id pub-id-type="pmc">5402811</article-id><article-id pub-id-type="publisher-id">AAM-15-114</article-id><article-id pub-id-type="doi">10.4103/1596-3519.188890</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Induction to delivery interval using transcervical Foley catheter plus oxytocin and vaginal misoprostol: A comparative study at Aminu Kano Teaching Hospital, Kano, Nigeria</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Garba</surname><given-names>Ibrahim</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Muhammed</surname><given-names>Abubakar Shehu</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name><surname>Muhammad</surname><given-names>Zakari</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Galadanci</surname><given-names>Hadiza Shehu</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Ayyuba</surname><given-names>Rabiu</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Abubakar</surname><given-names>Idris Sulaiman</given-names></name><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1">Department of Obstetrics and Gynaecology, Bayero University Kano, Aminu Kano Teaching Hospital, Kano, Nigeria</aff><aff id="aff2"><label>1</label>Department of Obstetrics and Gynaecology, Aminu Kano Teaching Hospital, Kano, Nigeria</aff><author-notes><corresp id="cor1"><bold>Correspondence to:</bold> Dr. Rabiu Ayyuba, Department of Obstetrics and Gynaecology, Bayero University Kano, Aminu Kano Teaching Hospital, Kano, Nigeria. E-mail: <email xlink:href="ayyubarabiu@yahoo.com">ayyubarabiu@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jul-Sep</season><year>2016</year></pub-date><volume>15</volume><issue>3</issue><fpage>114</fpage><lpage>119</lpage><permissions><copyright-statement>Copyright: &#x000a9; 2016 Annals of African Medicine</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><abstract><sec id="st1"><title>Background:</title><p>Induction of labor (IOL) is an artificial initiation of labor before its spontaneous onset for the purpose of delivery of the fetoplacental unit. Many factors are associated with its success in postdatism.</p></sec><sec id="st2"><title>Objective:</title><p>To compare the induction delivery intervals using transcervical Foley catheter plus oxytocin and vaginal misoprostol, and to identify the factors associated with successful induction among postdate singleton multiparae.</p></sec><sec id="st3"><title>Materials and Methods:</title><p>The study was a prospective randomized controlled trial of singleton multiparous pregnant women. They were randomized into two groups, one group for intravaginal misoprostol and the other group for transcervical Foley catheter insertion as a method of cervical ripening and IOL. The data were analyzed using SPSS version 17 computer software (SPSS Inc., IL, Chicago, USA). Comparisons of categorical variables were done using Chi-squared test, with <italic>P</italic> &#x0003c; 0.05 considered as significant. Student's <italic>t</italic>-test was used for continuous variables.</p></sec><sec id="st4"><title>Results:</title><p>The incidence of postdatism was found to be 136 (13.1%). The mean induction delivery time interval was shorter in the misoprostol group 70 (5.54 &#x000b1; 1.8 h) than in the Foley catheter oxytocin infusion group 66 (6.65 &#x000b1; 1.7 h) (<italic>P</italic> = 0.035). There was, however, no statistically significant difference in the maternal and neonatal outcomes when these two agents were used for cervical ripening and IOL. Higher parity and higher Bishop's score were the factors found to be associated with high success rate of IOL (<italic>P</italic> &#x0003c; 0.001).</p></sec><sec id="st5"><title>Conclusion:</title><p>Vaginal misoprostol resulted in shorter induction delivery time interval as compared to transcervical Foley catheter. High parity and high Bishop's scores were the factors found to be associated with the success of IOL.</p></sec></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><sec id="st6"><title>Contexte:</title><p>l&#x02019;induction du travail (IOL) est un artificial d&#x000e9;clenchement du travail avant son apparition spontan&#x000e9;e aux fins de livraison de l&#x02019;unit&#x000e9; fetoplacental. De nombreux facteurs sont associ&#x000e9;s &#x000e0; son succ&#x000e8;s en postdatism.</p></sec><sec id="st7"><title>Objectif:</title><p>Pour comparer les intervalles de livraison d&#x02019;induction &#x000e0; l&#x02019;aide d&#x02019;transcervicale cath&#x000e9;ter de Foley, plus l&#x02019;oxytocine et vaginal misoprostol, et d&#x02019;identifier les facteurs associ&#x000e9;s au succ&#x000e8;s de l&#x02019;induction chez postdatent multiparae singleton.</p></sec><sec id="st8"><title>Mat&#x000e9;riels et M&#x000e9;thodes:</title><p>l&#x02019;&#x000e9;tude a &#x000e9;t&#x000e9; un essai randomis&#x000e9; contr&#x000f4;l&#x000e9; prospectif de singleton multipare les femmes enceintes. Ils ont &#x000e9;t&#x000e9; randomis&#x000e9;s en deux groupes : l&#x02019;un pour l&#x02019; autre misoprostol et intravaginale Groupe pour l&#x02019;insertion du cath&#x000e9;ter de Foley transcervicales comme m&#x000e9;thode de maturation du col et iol. Les donn&#x000e9;es ont &#x000e9;t&#x000e9; analys&#x000e9;es &#x000e0; l&#x02019;aide de SPSS version 17 computer software (SPSS Inc., HE, Chicago, &#x000c9;tats-Unis). Les comparaisons des variables cat&#x000e9;goriques ont &#x000e9;t&#x000e9; effectu&#x000e9;es &#x000e0; l&#x02019;aide du test chi-carr&#x000e9;, avec <italic>P</italic> &#x0003c; 0,05 consid&#x000e9;r&#x000e9;es comme significatives. Le test t de Student a &#x000e9;t&#x000e9; utilis&#x000e9; pour les variables continues.</p></sec><sec id="st9"><title>R&#x000e9;sultats:</title><p>L&#x02019;incidence de postdatism a &#x000e9;t&#x000e9; trouv&#x000e9; &#x000e0; 136 (13,1 %). L&#x02019; intervalle de temps de livraison d&#x02019;induction moyenne &#x000e9;tait plus courte dans le misoprostol groupe 70 (5,54 &#x000b1; 1,8 h) que dans le cath&#x000e9;ter de Foley oxytocine groupe infusion 66 (6,65 &#x000b1; 1,7 h) (<italic>P</italic> = 0,035). Il y a, toutefois, aucune diff&#x000e9;rence statistiquement significatives de diff&#x000e9;rence dans les r&#x000e9;sultats maternels et n&#x000e9;onatals lorsque ces deux agents ont &#x000e9;t&#x000e9; utilis&#x000e9;es pour la maturation du col et IOL. Plus &#x000e9;lev&#x000e9; et une plus grande parit&#x000e9; Bishop&#x02019;s score &#x000e9;taient les facteurs associ&#x000e9;s aux taux de r&#x000e9;ussite &#x000e9;lev&#x000e9; de terres inuites (<italic>P</italic> &#x0003c; 0,001).</p></sec><sec id="st10"><title>Conclusion:</title><p>VAGINAL MISOPROSTOL entra&#x000ee;n&#x000e9; plus court intervalle de temps de livraison d&#x02019;induction par rapport &#x000e0; transcervicale cath&#x000e9;ter de Foley. La parit&#x000e9; &#x000e9;lev&#x000e9;e et haute Bishop&#x02019;s notes &#x000e9;taient les facteurs associ&#x000e9;s &#x000e0; la r&#x000e9;ussite de terres inuites.</p></sec></trans-abstract><kwd-group><kwd>Induction delivery interval</kwd><kwd>Kano</kwd><kwd>misoprostol</kwd><kwd>postdatism</kwd><kwd>transcervical catheter</kwd><kwd>Intervalle de livraison par induction</kwd><kwd>Kano</kwd><kwd>misoprostol</kwd><kwd>postdatism</kwd><kwd>transcervicale cath&#x000e9;ter</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Induction of labor (IOL) at term is a common obstetric intervention with many indications among which the most common is postdatism.[<xref rid="ref1" ref-type="bibr">1</xref><xref rid="ref2" ref-type="bibr">2</xref>]</p><p>About 15% of all gravid women with unfavorable Bishop's score may need cervical ripening[<xref rid="ref3" ref-type="bibr">3</xref><xref rid="ref4" ref-type="bibr">4</xref><xref rid="ref5" ref-type="bibr">5</xref><xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref>] for IOL. IOL is a technique for initiating uterine contraction to achieve delivery of the fetoplacental unit before the onset of spontaneous labor.[<xref rid="ref8" ref-type="bibr">8</xref>]</p><p>Postdatism, which has been known to be the most common indication of IOL, has an average frequency of 10%[<xref rid="ref9" ref-type="bibr">9</xref><xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref>] and occurs when pregnancy exceeds 40 weeks of gestational age (GA) beyond which pregnancy is advised to be terminated because of possible deterioration of placental function, which may jeopardize the intrauterine state of the fetus and can result in significant increase in perinatal morbidity and mortality as well as increased risk to the mother.[<xref rid="ref12" ref-type="bibr">12</xref><xref rid="ref13" ref-type="bibr">13</xref>]</p><p>There is a growing body of evidence suggesting that labor should be electively induced at 41 weeks of GA instead of expectant management.[<xref rid="ref14" ref-type="bibr">14</xref><xref rid="ref15" ref-type="bibr">15</xref><xref rid="ref16" ref-type="bibr">16</xref>] Although there are many methods for cervical ripening, there is no agreement in the choice of best and most proper method of cervical ripening, before IOL. The study was aimed to add to the existing literature and assist in providing the best method that gives maternal and neonatal outcomes and also short average induction delivery time interval.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><p>The study was a prospective randomized controlled trial among all consenting postdate singleton pregnant multigravidae who booked for an antenatal clinic at Aminu Kano Teaching Hospital and planned for IOL. Ethical approval was sought and obtained from the hospital ethical committee. It was conducted from February 01 to May 30, 2015.</p><p>The patients were recruited from the antenatal ward at 41 weeks 3 days GA for IOL with an unfavorable cervix. This was based on the hospital protocol. An informed consent was sought and obtained from each patient before recruitment.</p><p>A pretested questionnaire was administered before and completed after the delivery by the investigators until the minimum sample size was attained. Information recorded on the questionnaire included sociodemographic factors, last menstrual period, gravidity, parity, and GA. Others such as methods of delivery, maternal and perinatal outcomes were also obtained, and their respective responses were recorded. Computer-generated random numbers were used to allocate the study groups into either Foley catheter or vaginal misoprostol. The induction to delivery interval was calculated from cervical dilatation of 4 cm to the delivery of the fetus. The APGAR scores, maternal vital signs, estimated blood loss, and induction to delivery interval were recorded on the questionnaire.</p><p>The data were analyzed using SPSS version 17 computer software (SPSS Inc., IL, Chicago, USA). Comparison of categorical variables was done using Chi-square test with <italic>P</italic> &#x0003c; 0.05, which was considered significant. Student's <italic>t</italic>-test was used for continuous variables.</p></sec><sec sec-type="results" id="sec1-3"><title>Results</title><p>Data of one hundred and thirty-six participants were analyzed. The total number of deliveries during the period was 1038. The rate of IOL among multiparous pregnant women, who were carrying singleton fetuses, was found to be 136 (13.1%) of all deliveries.</p><p>The participants were comparable in their socioeconomic and demographic characteristics; the differences observed were not statistically significant [<xref ref-type="table" rid="T1">Table 1</xref>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Distribution of participants by their socioeconomic and demographic characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Variable</th><th align="center" rowspan="1" colspan="1">Misoprostol group (<italic>n</italic>=70) (%)</th><th align="center" rowspan="1" colspan="1">Foley catheter (plus oxytocin infusion) group (<italic>n</italic>=66) (%)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (in years)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x0003c;20</td><td align="center" rowspan="1" colspan="1">10 (14.3)</td><td align="center" rowspan="1" colspan="1">5 (7.6)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=3.52</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;20-34</td><td align="center" rowspan="1" colspan="1">45 (64.3)</td><td align="center" rowspan="1" colspan="1">52 (78.8)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic>=0.169</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02265;35</td><td align="center" rowspan="1" colspan="1">15 (21.4)</td><td align="center" rowspan="1" colspan="1">9 (13.6)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Educational status of the participants</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Nil</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=1.1</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Primary school</td><td align="center" rowspan="1" colspan="1">14 (20.0)</td><td align="center" rowspan="1" colspan="1">18 (27.3)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic>=0.06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Secondary school</td><td align="center" rowspan="1" colspan="1">30 (42.9)</td><td align="center" rowspan="1" colspan="1">27 (49.9)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Tertiary education</td><td align="center" rowspan="1" colspan="1">26 (37.1)</td><td align="center" rowspan="1" colspan="1">21 (31.8)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Religion</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Islam</td><td align="center" rowspan="1" colspan="1">62 (88.6)</td><td align="center" rowspan="1" colspan="1">63 (95.5)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=1.34</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Christianity</td><td align="center" rowspan="1" colspan="1">8 (11.4)</td><td align="center" rowspan="1" colspan="1">3 (4.5)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic>=0.25</td></tr><tr><td align="left" rowspan="1" colspan="1">Tribe</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Hausa</td><td align="center" rowspan="1" colspan="1">50 (71.4)</td><td align="center" rowspan="1" colspan="1">51 (77.2)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=1.06</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Fulani</td><td align="center" rowspan="1" colspan="1">8 (11.4)</td><td align="center" rowspan="1" colspan="1">9 (13.6)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic>=0.58</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Igbo</td><td align="center" rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1">3 (4.6)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yoruba</td><td align="center" rowspan="1" colspan="1">6 (8.6)</td><td align="center" rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Others</td><td align="center" rowspan="1" colspan="1">6 (8.6)</td><td align="center" rowspan="1" colspan="1">3 (4.6)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Occupation</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Homemaker</td><td align="center" rowspan="1" colspan="1">48 (68.6)</td><td align="center" rowspan="1" colspan="1">48 (72.7)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=3.37</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Civil servant</td><td align="center" rowspan="1" colspan="1">4 (5.7)</td><td align="center" rowspan="1" colspan="1">6 (9.1)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic>=0.34</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Student</td><td align="center" rowspan="1" colspan="1">10 (14.2)</td><td align="center" rowspan="1" colspan="1">6 (9.1)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Trader</td><td align="center" rowspan="1" colspan="1">2 (2.9)</td><td align="center" rowspan="1" colspan="1">6 (9.1)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Others</td><td align="center" rowspan="1" colspan="1">6 (8.6)</td><td align="center" rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><p>The majority of the participants in both groups belonged to the age group of 20&#x02013;34, 45 (64.3%) and 52 (78.8%) in the misoprostol and intracervical Foley catheter group, respectively.</p><p><xref ref-type="fig" rid="F1">Figure 1</xref> shows that para 1 from the misoprostol and Foley catheter groups were 26 (37.1%) and 20 (30.3%), respectively. Whereas 18 (27.3%) and 10 (14.3%) had a parity of 4 in the Foley catheter and misoprostol group, respectively.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>Distribution of the patients based on their parity</p></caption><graphic xlink:href="AAM-15-114-g001"/></fig><p>The differences were not statistically significant (&#x003c7;<sup>2</sup> = 5.09, <italic>P</italic> = 0.165). None had ventouse- or forceps-assisted vaginal delivery.</p><p>The majority of the participants from both groups had spontaneous vaginal delivery (SVD); 14 patients had cesarean delivery in the vaginal misoprostol group.</p><p><xref ref-type="table" rid="T2">Table 2</xref> shows the number of neonates who had greenish meconium-stained amniotic fluid and failure to progress in the second stage of labor.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Mode of delivery, indications for cesarean section, and the induction to delivery interval of the studied group</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Groups</th><th align="center" rowspan="1" colspan="1">Misoprostol group (<italic>n</italic>=70) (%)</th><th align="center" rowspan="1" colspan="1">Foley catheter (plus oxytocin infusion) group (<italic>n</italic>=66) (%)</th><th align="center" valign="top" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SVD</td><td align="center" rowspan="1" colspan="1">56 (80.0)</td><td align="center" rowspan="1" colspan="1">60 (90.9)</td><td align="center" valign="top" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=3.22</td></tr><tr><td align="left" rowspan="1" colspan="1">C/S</td><td align="center" rowspan="1" colspan="1">14 (20.0)</td><td align="center" rowspan="1" colspan="1">6 (9.1)</td><td align="center" rowspan="1" colspan="1"><italic>P</italic>=0.073</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">70 (100)</td><td align="center" rowspan="1" colspan="1">66 (100)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Indications for cesarean section</bold></td><td align="center" rowspan="1" colspan="1"><bold>Misoprostol group (<italic>n</italic>=14) (%)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Foley catheter (plus oxytocin infusion) group (<italic>n</italic>=6) (%)</bold></td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">No progress in the 2<sup>nd</sup> stage of labor</td><td align="center" rowspan="1" colspan="1">10 (71.4)</td><td align="center" rowspan="1" colspan="1">6 (100)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Meconium-stained amniotic fluid (thick greenish)</td><td align="center" rowspan="1" colspan="1">4 (28.6)</td><td align="center" rowspan="1" colspan="1">None</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">14 (100)</td><td align="center" rowspan="1" colspan="1">6 (100)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Induction to delivery interval</bold></td><td align="center" rowspan="1" colspan="1"><bold>Misoprostol group (<italic>n</italic>=70)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Foley catheter (plus oxytocin infusion) group (<italic>n</italic>=66)</bold></td><td align="center" rowspan="1" colspan="1"><bold><italic>P</italic></bold></td></tr><tr><td align="left" rowspan="1" colspan="1">Induction to delivery period (from cervical dilation of 4 and above)</td><td align="center" rowspan="1" colspan="1">5.54&#x000b1;1.8 h</td><td align="center" rowspan="1" colspan="1">6.65&#x000b1;1.7 h</td><td align="center" rowspan="1" colspan="1">0.035</td></tr></tbody></table><table-wrap-foot><fn><p>SVD: Spontaneous vaginal delivery, C/S: Cesarean section</p></fn></table-wrap-foot></table-wrap><p>The induction delivery interval was seen to be shorter in the misoprostol group and longer in the Foley catheter plus oxytocin infusion group. The difference was statistically significant [<xref ref-type="table" rid="T2">Table 2</xref>].</p><p>The mean 1<sup>st</sup> min APGAR scores were found to be 7.36 &#x000b1; 1.2 and 7.60 &#x000b1; 1 and that of the 5<sup>th</sup> min were 8.96 &#x000b1; 8.04 and 8.90 &#x000b1; 0.72 in the misoprostol group and Foley catheter plus oxytocin group, respectively [<xref ref-type="table" rid="T3">Table 3</xref>]. The differences were not statistically significant (<italic>P</italic> = 0.46; 1<sup>st</sup> min and <italic>P</italic> = 0.78; 5<sup>th</sup> min, respectively).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Outcome measures</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Groups</th><th align="center" rowspan="1" colspan="1">Misoprostol group (<italic>n</italic>=70)</th><th align="center" rowspan="1" colspan="1">Foley catheter (plus oxytocin infusion) group (<italic>n</italic>=66)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">APGAR scores</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;The mean first minute APGAR score</td><td align="center" rowspan="1" colspan="1">7.36&#x000b1;1.2</td><td align="center" rowspan="1" colspan="1">7.60&#x000b1;1</td><td align="center" rowspan="1" colspan="1">0.46</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;The mean fifth minute APGAR score</td><td align="center" rowspan="1" colspan="1">8.96&#x000b1;0.84</td><td align="center" rowspan="1" colspan="1">8.90&#x000b1;0.72</td><td align="center" rowspan="1" colspan="1">0.78</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Bishop&#x02019;s score</bold></td><td align="center" rowspan="1" colspan="1"><bold>Mean total time from insertion of the agent to delivery in the Foley catheter plus oxytocin group (<italic>n</italic>=60)</bold></td><td align="center" rowspan="1" colspan="1"><bold>Mean total time from insertion of the agent to delivery in the misoprostol group (<italic>n</italic>=56)</bold></td><td align="center" rowspan="1" colspan="1"><bold><italic>P</italic>&#x0003c;0.05</bold></td></tr><tr><td align="left" rowspan="1" colspan="1">0-2</td><td align="center" rowspan="1" colspan="1">37&#x000b1;8.3 h</td><td align="center" rowspan="1" colspan="1">25.32&#x000b1;7.28 h</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">3-5</td><td align="center" rowspan="1" colspan="1">22.85&#x000b1;7.4</td><td align="center" rowspan="1" colspan="1">9.64&#x000b1;3.7 h</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Interventions (%)</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Failed induction of labor</td><td align="center" rowspan="1" colspan="1">14 (20.0)</td><td align="center" rowspan="1" colspan="1">6 (9.1)</td><td align="center" rowspan="1" colspan="1"><italic>&#x003c7;</italic><sup>2</sup>=48.7 <italic>P</italic>&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Need for amniotomy</td><td align="center" rowspan="1" colspan="1">50 (71.4)</td><td align="center" rowspan="1" colspan="1">48 (72.7)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Need for oxytocin infusion</td><td align="center" rowspan="1" colspan="1">6 (8.6)</td><td align="center" rowspan="1" colspan="1">48 (72.7)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Use of episiotomy</td><td align="center" rowspan="1" colspan="1">38 (54.3)</td><td align="center" rowspan="1" colspan="1">12 (18.2)</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><p>Failed IOL was more in the vaginal misoprostol group [<xref ref-type="table" rid="T3">Table 3</xref>].</p><p>All the participants had an ultrasound scan, 38 (28%) had it in the 1<sup>st</sup> trimester, 45 (33%) had it in the 2<sup>nd</sup> trimester whereas 53 (39%) had it in the 3<sup>rd</sup> trimester.</p><p>The mean gestation age at booking was found to be 24.53 &#x000b1; 7.2 weeks. All the fetuses, i.e., 136 (100%) had reassuring cardiotocography findings.</p><p>Only 60 (44.1%) patients remembered their last menstrual period, whereas 57 (41.9%) remembered the birth weight of their neonate(s) at birth. The number of times misoprostol (fifty micro grams) used was only once in 26 (37.1%), twice in 28 (40.0%), thrice in 6 (8.6%), and 4 times in 10 (14.3%). Forty-two (63.6%) had the agent passed once whereas 24 (36.4%) had the agent passed twice. The mean maternal blood loss was found to be 161 &#x000b1; 54.3 ml in the Foley catheter plus oxytocin infusion group and 151 &#x000b1; 37.55 ml in the misoprostol group.</p><p>No pregnant woman had pyrexia in the Foley catheter plus oxytocin infusion group whereas 10 (14.3%) patients developed pyrexia in the misoprostol group.</p><p>On the distribution of the neonates based on sex, 72 (52.9%) were males, whereas 64 (47.1%) were females. The need for Intensive Care Unit (ICU) admission was observed in 2 (2.9%) neonates and they were both from the misoprostol group, none from the Foley catheter plus oxytocin infusion group. The number of patients that had previous IOL from the misoprostol group was 8 (11.4%) whereas in the Foley catheter plus oxytocin infusion group, it was 9 (13.6%).</p><p>The mean total time from insertion of the agent to delivery is shown in <xref ref-type="table" rid="T4">Table 4</xref>. The difference between the two groups was statistically significant (<italic>P</italic> &#x0003c; 0.001).</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>The mean total time from insertion of the agent to delivery with respect to parity</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1">Parity</th><th align="center" rowspan="1" colspan="1">The mean total time from insertion of the agent to delivery with respect to parity in the Foley catheter plus oxytocin group (<italic>n</italic>=60) (h)</th><th align="center" rowspan="1" colspan="1">The mean total time from insertion of the agent to delivery with respect to parity in the misoprostol group (<italic>n</italic>=56) (h)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1-2</td><td align="center" rowspan="1" colspan="1">35.55&#x000b1;9.7</td><td align="center" rowspan="1" colspan="1">24.29&#x000b1;7.1</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">3-4</td><td align="center" rowspan="1" colspan="1">17.90&#x000b1;6.65</td><td align="center" rowspan="1" colspan="1">10.68&#x000b1;2.45</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>The incidence of postdatism within the study period was found to be 13.1% of all deliveries in the Aminu Kano Teaching Hospital. This was higher than 6.9% reported by Naeye.[<xref rid="ref17" ref-type="bibr">17</xref>] This was probably because they used early ultrasound scan for dating of pregnancies during their study period, which is more accurate than the one done late in pregnancies. Late ultrasound scanning done in this study could have contributed to the high incidence. The incidence was, however, lower than 17% reported by Hovi <italic>et al</italic>.[<xref rid="ref18" ref-type="bibr">18</xref>]</p><p>The rate of SVD was found to be 90.9% in the Foley catheter plus oxytocin group and 80% in the misoprostol group. This was comparable to the findings of Ekele and Isah[<xref rid="ref19" ref-type="bibr">19</xref>] where the success rate for misoprostol used for IOL was 96% and that of the intracervical Foley catheter was 91%. Owolabi <italic>et al</italic>.[<xref rid="ref20" ref-type="bibr">20</xref>] reported that the success rate between vaginal misoprostol and intracervical Foley catheter used for IOL was the same. In this study, the difference was probably because the number of patients who had no progress in the 2<sup>nd</sup> stage of labor was higher in misoprostol group (10) than that of Foley catheter plus oxytocin infusion (six). There was no case of fetal distress or meconium-stained liquor in the Foley catheter plus oxytocin infusion group. The difference was, however, not statistically significant (<italic>P</italic> = 0.073).</p><p>There was no statistically significant difference in the socioeconomic and demographic characteristics of the study group. This provides adequate basis for comparison.</p><p>The mean induction to delivery time interval, which was from the time the Bishop's scores became favorable (inducible) to the delivery of the fetus, was found to be shorter in the misoprostol group (5.54 &#x000b1; 1.8 h) than that of the Foley catheter plus oxytocin infusion group (6.65 &#x000b1; 1.7 h). Student's <italic>t</italic>-test was used to test for significance, and the result was statistically significant (<italic>P</italic> = 0.035). The finding was comparable to similar studies done elsewhere.[<xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref22" ref-type="bibr">22</xref><xref rid="ref23" ref-type="bibr">23</xref>]</p><p>None of the neonates from the Foley catheter plus oxytocin infusion group had thick, greenish meconium-stained amniotic fluid. Whereas 4 (5.7%) of the neonates in the misoprostol group had meconium-stained amniotic fluid. The result was similar to the finding of Jindal <italic>et al</italic>.,[<xref rid="ref22" ref-type="bibr">22</xref>] but lower than that obtained by Vahid Roudsari <italic>et al</italic>.[<xref rid="ref24" ref-type="bibr">24</xref>]</p><p>The need for neonatal intensive care admission was found to be 2.9% among the neonates who were delivered from mothers who had their labor induced with misoprostol, whereas none from the Foley catheter plus oxytocin infusion group needed intensive care admission. This was also comparable to the findings by Jindal <italic>et al</italic>.,[<xref rid="ref22" ref-type="bibr">22</xref>] while Owolabi <italic>et al</italic>.[<xref rid="ref20" ref-type="bibr">20</xref>] showed no difference in ICU admissions between the two groups.</p><p>Cesarean delivery rates were found to be 14 (20.0%) from the misoprostol group and 6 (9.1%) from the Foley catheter plus oxytocin infusion group. The difference was not statistically significant (<italic>P</italic> = 0.073). The findings were similar to other findings elsewhere.[<xref rid="ref20" ref-type="bibr">20</xref><xref rid="ref21" ref-type="bibr">21</xref><xref rid="ref22" ref-type="bibr">22</xref><xref rid="ref23" ref-type="bibr">23</xref><xref rid="ref24" ref-type="bibr">24</xref>]</p><p>Uterine tachysystole did not occur in the Foley catheter plus oxytocin infusion group, but 2.9% of patients who had their labor induced with vaginal misoprostol had uterine tachysystole. The findings were similar to those from Vahid Roudsari <italic>et al</italic>.[<xref rid="ref24" ref-type="bibr">24</xref>] in Iran, but lower than the findings from Jindal <italic>et al</italic>.[<xref rid="ref22" ref-type="bibr">22</xref>] in India. This was probably because of the higher number of times the misoprostol was used (up to six doses).</p><p>Pyrexia was found to occur in 10 (14.3%) patients in the misoprostol group, but none from the Foley catheter plus oxytocin infusion group.</p><p>The mean maternal blood loss was 151 &#x000b1; 37.55 ml in the misoprostol group and 161 &#x000b1; 54.3 ml in the Foley catheter plus oxytocin infusion group. The difference was not statistically significant (<italic>P</italic> = 0.437). None of the patients had primary postpartum hemorrhage in either group.</p><p>Higher Bishop's scores and higher parity were the factors found to be associated with high success rates of IOL. The differences in the results were statistically significant (<italic>P</italic> &#x0003c; 0.001). These were comparable to the findings elsewhere.[<xref rid="ref23" ref-type="bibr">23</xref><xref rid="ref25" ref-type="bibr">25</xref>]</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>The incidence of postdatism among multiparous pregnant women was found to be 13.1% of all deliveries. Use of vaginal misoprostol for cervical ripening and IOL was found to result in shorter induction to the delivery time interval when compared to intracervical Foley catheter plus oxytocin infusion.</p><p>There was, however, no statistically significant difference in the maternal and neonatal outcomes when these two agents were used for cervical ripening and IOL.</p><p>Higher Bishop's scores and higher parity were the factors found to be associated with high success rate of IOL among those who had SVD.</p><sec id="sec2-1"><title>Limitation of the study</title><p>The indication for IOL in this study was only postdatism; hence, the findings cannot be generalized on patients who have other indications for labor induction.</p></sec><sec id="sec2-2"><title>Recommendation</title><p>The use of vaginal misoprostol for cervical ripening and IOL, among postdate multiparous singleton pregnant women, is recommended and preferred over Foley catheter plus oxytocin infusion.</p></sec><sec id="sec2-3"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-4" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawani</surname><given-names>OL</given-names></name><name><surname>Onyebuchi</surname><given-names>AK</given-names></name><name><surname>Iyoke</surname><given-names>CA</given-names></name><name><surname>Okafo</surname><given-names>CN</given-names></name><name><surname>Ajah</surname><given-names>LO</given-names></name></person-group><article-title>Obstetric outcome and significance of labour induction in a health resource poor setting</article-title><source>Obstet Gynecol Int 2014</source><year>2014</year><fpage>1</fpage><lpage>5</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bako</surname><given-names>BG</given-names></name><name><surname>Obed</surname><given-names>JY</given-names></name><name><surname>Sanusi</surname><given-names>I</given-names></name></person-group><article-title>Methods of induction of labour at the University of Maiduguri Teaching Hospital, Maiduguri: A 4-year review</article-title><source>Niger J Med</source><year>2008</year><volume>17</volume><fpage>139</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">18686826</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mbele</surname><given-names>AM</given-names></name><name><surname>Makin</surname><given-names>JD</given-names></name><name><surname>Pattinson</surname><given-names>RC</given-names></name></person-group><article-title>Can the outcome of induction of labour with oral misoprostol be predicted</article-title><source>S Afr Med J</source><year>2007</year><volume>97</volume><fpage>289</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">17446955</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choy-Hee</surname><given-names>L</given-names></name><name><surname>Raynor</surname><given-names>BD</given-names></name></person-group><article-title>Misoprostol induction of labor among women with a history of cesarean delivery</article-title><source>Am J Obstet Gynecol</source><year>2001</year><volume>184</volume><fpage>1115</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">11349173</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fletcher</surname><given-names>H</given-names></name><name><surname>Mitchell</surname><given-names>S</given-names></name><name><surname>Frederick</surname><given-names>J</given-names></name><name><surname>Simeon</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>D</given-names></name></person-group><article-title>Intravaginal misoprostol versus dinoprostone as cervical ripening and labor-inducing agents</article-title><source>Obstet Gynecol</source><year>1994</year><volume>83</volume><fpage>244</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">8290188</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmeyr</surname><given-names>GJ</given-names></name><name><surname>Gulmezoglu</surname><given-names>AM</given-names></name></person-group><article-title>Vaginal misoprostol for cervical ripening and labour induction in late pregnancy</article-title><source>Cochrane Database Syst Rev</source><year>2000</year><volume>2</volume><fpage>CD000941</fpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartusevicius</surname><given-names>A</given-names></name><name><surname>Barcaite</surname><given-names>E</given-names></name><name><surname>Nadisauskiene</surname><given-names>R</given-names></name></person-group><article-title>Oral, vaginal and sublingual misoprostol for induction of labor</article-title><source>Int J Gynaecol Obstet</source><year>2005</year><volume>91</volume><fpage>2</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16109419</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>JA</given-names></name><name><surname>Hamilton</surname><given-names>BE</given-names></name><name><surname>Ventura</surname><given-names>SJ</given-names></name><name><surname>Osterman</surname><given-names>MJ</given-names></name><name><surname>Kirmeyer</surname><given-names>S</given-names></name><name><surname>Mathews</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Births: Final data for 2009</article-title><source>Natl Vital Stat Rep</source><year>2011</year><volume>60</volume><fpage>1</fpage><lpage>70</lpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sachs</surname><given-names>BP</given-names></name><name><surname>Friedman</surname><given-names>EA</given-names></name></person-group><article-title>Results of an epidemiologic study of postdate pregnancy</article-title><source>J Reprod Med</source><year>1986</year><volume>31</volume><fpage>162</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">3701715</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayburn</surname><given-names>WF</given-names></name><name><surname>Chang</surname><given-names>FE</given-names></name></person-group><article-title>Management of the uncomplicated postdate pregnancy</article-title><source>J Reprod Med</source><year>1981</year><volume>26</volume><fpage>93</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">7218225</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beischer</surname><given-names>NA</given-names></name><name><surname>Evans</surname><given-names>JH</given-names></name><name><surname>Townsend</surname><given-names>L</given-names></name></person-group><article-title>Studies in prolonged pregnancy. I. The incidence of prolonged pregnancy</article-title><source>Am J Obstet Gynecol</source><year>1969</year><volume>103</volume><fpage>476</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">5764176</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilder</surname><given-names>L</given-names></name><name><surname>Costeloe</surname><given-names>K</given-names></name><name><surname>Thilaganathan</surname><given-names>B</given-names></name></person-group><article-title>Prolonged pregnancy: Evaluating gestation-specific risks of fetal and infant mortality</article-title><source>Br J Obstet Gynaecol</source><year>1998</year><volume>105</volume><fpage>169</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">9501781</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotzias</surname><given-names>CS</given-names></name><name><surname>Paterson-Brown</surname><given-names>S</given-names></name><name><surname>Fisk</surname><given-names>NM</given-names></name></person-group><article-title>Prospective risk of unexplained stillbirth in singleton pregnancies at term: Population based analysis</article-title><source>BMJ</source><year>1999</year><volume>319</volume><fpage>287</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">10426736</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rand</surname><given-names>L</given-names></name><name><surname>Robinson</surname><given-names>JN</given-names></name><name><surname>Economy</surname><given-names>KE</given-names></name><name><surname>Norwitz</surname><given-names>ER</given-names></name></person-group><article-title>Post-term induction of labor revisited</article-title><source>Obstet Gynecol</source><year>2000</year><volume>96</volume><issue>5 Pt 1</issue><fpage>779</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">11042317</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannah</surname><given-names>ME</given-names></name><name><surname>Hannah</surname><given-names>WJ</given-names></name><name><surname>Hellmann</surname><given-names>J</given-names></name><name><surname>Hewson</surname><given-names>S</given-names></name><name><surname>Milner</surname><given-names>R</given-names></name><name><surname>Willan</surname><given-names>A</given-names></name></person-group><article-title>Induction of labor as compared with serial antenatal monitoring in post-term pregnancy. A randomized controlled trial. The Canadian Multicenter Post-term Pregnancy Trial Group</article-title><source>N Engl J Med</source><year>1992</year><volume>326</volume><fpage>1587</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">1584259</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crowley</surname><given-names>P</given-names></name></person-group><article-title>Interventions for preventing or improving the outcome of delivery at or beyond term</article-title><source>Cochrane Database Syst Rev</source><year>2000</year><volume>2</volume><fpage>CD000170</fpage></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naeye</surname><given-names>RL</given-names></name></person-group><article-title>Causes of perinatal mortality excess in prolonged gestations</article-title><source>Am J Epidemiol</source><year>1978</year><volume>108</volume><fpage>429</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">727213</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hovi</surname><given-names>M</given-names></name><name><surname>Raatikainen</surname><given-names>K</given-names></name><name><surname>Heiskanen</surname><given-names>N</given-names></name><name><surname>Heinonen</surname><given-names>S</given-names></name></person-group><article-title>Obstetric outcome in post-term pregnancies: Time for reappraisal in clinical management</article-title><source>Acta Obstet Gynecol Scand</source><year>2006</year><volume>85</volume><fpage>805</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16817077</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekele</surname><given-names>BA</given-names></name><name><surname>Isah</surname><given-names>AY</given-names></name></person-group><article-title>Cervical ripening: How long can the Foley catheter safely remain in the cervical canal?</article-title><source>Afr J Reprod Health</source><year>2002</year><volume>6</volume><fpage>98</fpage><lpage>102</lpage><pub-id pub-id-type="pmid">12685414</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owolabi</surname><given-names>AT</given-names></name><name><surname>Kuti</surname><given-names>O</given-names></name><name><surname>Ogunlola</surname><given-names>IO</given-names></name></person-group><article-title>Randomised trial of intravaginal misoprostol and intracervical Foley catheter for cervical ripening and induction of labour</article-title><source>J Obstet Gynaecol</source><year>2005</year><volume>25</volume><fpage>565</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16234141</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ekele</surname><given-names>BA</given-names></name><name><surname>Nnadi</surname><given-names>DC</given-names></name><name><surname>Gana</surname><given-names>MA</given-names></name><name><surname>Shehu</surname><given-names>CE</given-names></name><name><surname>Ahmed</surname><given-names>Y</given-names></name><name><surname>Nwobodo</surname><given-names>EI</given-names></name></person-group><article-title>Misoprostol use for cervical ripening and induction of labour in a Nigerian teaching hospital</article-title><source>Niger J Clin Pract</source><year>2007</year><volume>10</volume><fpage>234</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">18072452</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jindal</surname><given-names>P</given-names></name><name><surname>Gill</surname><given-names>BK</given-names></name><name><surname>Tirath</surname><given-names>B</given-names></name></person-group><article-title>A comparison of vaginal misoprostol versus Foley catheter with oxytocin for induction of labour</article-title><source>J Obstet Gynaecol India</source><year>2007</year><volume>57</volume><fpage>42</fpage><lpage>7</lpage></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferdous</surname><given-names>J</given-names></name><name><surname>Khanam</surname><given-names>NN</given-names></name><name><surname>Begum</surname><given-names>MR</given-names></name><name><surname>Akhter</surname><given-names>S</given-names></name></person-group><article-title>Cervical ripening: Comparative study between intra-cervical ballooning by Foley catheter and by intra-vaginal misoprostol tablet</article-title><source>J Bangladesh Coll Phys Surg</source><year>2009</year><volume>27</volume><fpage>1</fpage><lpage>12</lpage></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vahid Roudsari</surname><given-names>F</given-names></name><name><surname>Ayati</surname><given-names>S</given-names></name><name><surname>Ghasemi</surname><given-names>M</given-names></name><name><surname>Hasanzadeh Mofrad</surname><given-names>M</given-names></name><name><surname>Shakeri</surname><given-names>MT</given-names></name><name><surname>Farshidi</surname><given-names>F</given-names></name><etal/></person-group><article-title>Comparison of vaginal misoprostol with Foley catheter for cervical ripening and induction of labor</article-title><source>Iran J Pharm Res</source><year>2011</year><volume>10</volume><fpage>149</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">24363694</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonen</surname><given-names>R</given-names></name><name><surname>Degani</surname><given-names>S</given-names></name><name><surname>Ron</surname><given-names>A</given-names></name></person-group><article-title>Prediction of successful induction of labor: Comparison of transvaginal ultrasonography and the Bishop score</article-title><source>Eur J Ultrasound</source><year>1998</year><volume>7</volume><fpage>183</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">9700213</pub-id></element-citation></ref></ref-list></back></article>